India to Belarus: Epirubicin Export Trade Route

The India to Belarus Epirubicin corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $199.5K USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's epirubicin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $33.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with epirubicin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 23.9%, placing it at rank #9 among India's top epirubicin export destinations globally.

On the import side, key buyers of Indian epirubicin in Belarus include RUP "BELPHARMACIA", RUP "BELPHARMACIA" . RUP "BELPHARMACIA" is the single largest importer with 4 shipments valued at $103.6K USD.

India's epirubicin exports to Belarus are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Belarus benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 100% of total trade value on this route. The average shipment value of $33.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as epirubicin-kabi injection 50mg/25ml vial and epirubicin-kabi injection 10mg/5ml vial, suggesting that buyers in Belarus tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RUP "BELPHARMACIA" is the largest importer with 4 shipments worth $103.6K USD — representing 52% of all epirubicin imports from India on this route.